ACC CardiaCast: Risk-Benefit Analysis and Dosing

This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.

Subscribe on iTunes | Subscribe on Google Play | View in the Educational Activity

Clinical Topics: Diabetes and Cardiometabolic Disease

Keywords: CardiaCast, Diabetes Mellitus, Diabetes Mellitus, Type 2, Cardiotonic Agents, Metabolic Syndrome X

< Back to Listings